Utilizing Private Pharmacies to Initiate High-risk Young Individuals on PrEP in South Africa

NCT07006246 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

1900

Enrollment

OTHER

Sponsor class

Conditions

HIV Infection

Interventions

DRUG: Tenofovir disoproxil fumarate + lamivudine/emtricitabine (TDF+3TC /FTC)

Sponsor

Professor Francois Venter

Collaborators

[object Object]